Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,726 people get AET articles and Market Currents by email alert.

Get email alerts on AET »

AET

Aetna, Inc.

5/19/2013, 11:05 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 17, 4:22 PM Aetna (AET) declares $0.20/share quarterly dividend, in line with previous. Forward yield 1.33%. For shareholders of record July 11. Payable July 26. Ex-div date July 09. (PR) Comment! [Dividends]
Tuesday, April 30, 7:50 AM More on Aetna's (AET) Q1: Although rising expenses offset higher revenues, AET's operating expense ratio fell and memberships grew for the fourth straight quarter as Medicare business was strong. Memberships are projected to be 18.4M by the end of the year. The company also boosted its outlook, saying it now sees operating earnings of $5.50-5.60 per share for FY13. (PR) Comment! [Healthcare, Earnings]
Tuesday, April 30, 6:01 AM Aetna (AET): Q1 EPS of $1.50 beats by $0.12. Revenue of $9.51B (+7% Y/Y) misses by $0.14B. (PR) Comment! [Earnings, Breaking News, Tech]
Tuesday, April 30, 12:05 AM Notable earnings before Tuesday’s open: ABFS, AET, AGCO, AMED, ARCO, AVP, BEN, BP, CIE, CMI, CNH, COCO, CRIS, CYNO, DBD, DDD, DPZ, ECL, EPD, ESV, EXAS, FCH, FIS, FLWS, GAS, GOV, HCLP, HCP, HEP, HNR, HOT, HRS, HUN, HW, IVZ, KLIC, LM, MCGC, MHP, MLM, MNTA, MPC, MPLX, MSO, MTG, MTOR, MWV, NEE, NI, NYX, ODP, OSK, PBI, PEG, PES, PFE, ROC, SAVE, SIRI, TFX, THC, TRI, TRW, UBS, UDR, VLO, VSH, WEC, X, XYL, ZTS Comment! [Earnings]
Monday, April 29, 5:30 PM Notable earnings before Tuesday’s open: ABFS, AET, AGCO, AMED, ARCO, AVP, BEN, BP, CIE, CMI, CNH, COCO, CRIS, CYNO, DBD, DDD, DPZ, ECL, EPD, ESV, EXAS, FCH, FIS, FLWS, GAS, GOV, HCLP, HCP, HEP, HNR, HOT, HRS, HUN, HW, IVZ, KLIC, LM, MCGC, MHP, MLM, MNTA, MPC, MPLX, MSO, MTG, MTOR, MWV, NEE, NI, NYX, ODP, OSK, PBI, PEG, PES, PFE, ROC, SAVE, SIRI, TFX, THC, TRI, TRW, UBS, UDR, VLO, VSH, WEC, X, XYL, ZTS 1 Comment [Earnings]
Wednesday, April 17, 12:33 PM The big surge in health care stocks earlier this month just prior to the government's decision on Medicare Advantage rates may have been due to an email to sent by a former top congressional aide who now happens to be an outside lobbyist for Humana (HUM -1.9%). The email, which is now subject to an SEC probe, was sent to a Washington investment-research firm and circulated to clients just minutes before the close of trading, saying that "credible sources" had told them a decision had been made to restore the payments. 4 Comments [Healthcare]
Monday, April 1, 6:12 PM The Centers for Medicare and Medicaid Services, after originally calling for reducing Medicare Advantage payments in February, seem to have reversed course, now projecting that combined growth in Medicare Advantage rates and fee-for-service rates will be 3.3%. Though it's unclear precisely what that may mean for health insurers, the markets are taking it as a positive: HUM +9%, AET +2.3%, WCG +4.1%, UNH +4% AH. 3 Comments [Healthcare, On the Move]
Monday, April 1, 4:08 PM Health insurers surge into the close as the final notice on Medicare Advantage reimbursement is due today: Humana (HUM +8.6%), UnitedHealth (UNH +3.1%), Wellcare Healthplans (WCG +3.9%), Coventry Health (CVH +1%) Centene (CNC +1%) and Aetna (AET +2.5%). Comment! [Healthcare, On the Move]
Tuesday, February 19, 9:39 AM It's not just Humana (-9.6%) suffering from prospective declines in reimbursement rates for Medicare Advantage plans in 2014, with UnitedHealth (UNH) -5.2%, Cigna (CI) -5.5%, Aetna (AET) -3.5% and Universal America (UAM) -8.95%. 7 Comments [Healthcare, On the Move]
Wednesday, February 6, 8:05 AM More on Coventry Health Care (CVH) Q4: net profit +39% to $119.3M. Operating expenses +9.6% despite the medical-loss ratio falling to 82.7% from 84.4% in Q3, and membership declining to 5.36M from 5.37M. Aetna (AET) investors are likely to take an interest, given that the company is buying Coventry for $5.7B. Comment! [Earnings, Healthcare]
Thursday, January 31, 8:07 AM More on Aetna (AET) Q4: net profit -49% to $190.1M, partly because of $120M in litigation expenses and other one-time items. Medical benefit ratio rises to 84.1% from 80.7%, membership +64K to 18.2M. Affirms guidance for FY EPS of at least $5.40. Names Shawn Guertin as CFO to replace Joseph Zubretsky, who will head a new unit called National Businesses. Guertin was CFO at Coventry Healthcare, which Aetna is buying. Comment! [Healthcare, Earnings]
Thursday, January 31, 6:01 AM Aetna (AET): Q4 EPS of $0.94 misses by $0.02. Revenue of $8.96B (+5% Y/Y) misses by $0.01B. (PR) Comment! [Earnings, Breaking News, Financials]
Thursday, January 31, 12:05 AM Notable earnings before Thursday’s open: AET, ALKS, AN, APU, AZN, BEAV, BLL, BMS, BX, CAM, CL, CNH, CNX, COCO, CRR, D, DB, DNKN, DOW, EPD, ERIC, EXXI, HAR, HGG, HP, HSH, HSY, IVZ, LQDT, MA, MJN, MO, MTG, MWW, NDAQ, NVO, OXY, PBI, PCAR, PENN, PHM, POT, R, RCL, RGLD, SHW, TE, TEN, TMO, TWC, UA, UGI, UPS, VIAB, WHR, XEL, ZMH Comment! [Earnings]
Wednesday, January 30, 5:30 PM Notable earnings before Thursday’s open: AET, ALKS, AN, APU, AZN, BEAV, BLL, BMS, BX, CAM, CL, CNH, CNX, COCO, CRR, D, DB, DNKN, DOW, EPD, ERIC, EXXI, HAR, HGG, HP, HSH, HSY, IVZ, LQDT, MA, MJN, MO, MTG, MWW, NDAQ, NVO, OXY, PBI, PCAR, PENN, PHM, POT, R, RCL, RGLD, SHW, TE, TEN, TMO, TWC, UA, UGI, UPS, VIAB, WHR, XEL, ZMH Comment! [Earnings]
Tuesday, January 22, 10:08 AM Aetna (AET +0.5%) agrees to sell its Medicaid business Missouri Care to WellCare Health Plans (WCG -0.3%) as part of Aetna's $5.6B acquisition of Coventry Health Care (CVH +0.1%). A combination of Aetna's and Coventry's Medicaid plans in Missouri would exceed permissible membership thresholds under the state's contracts. Financial terms weren't disclosed. (PR) Comment! [Healthcare, M&A]
Sunday, December 30, 2012, 11:35 AM At $28K a vial, Questcor's (QCOR) Acthar has propelled shares to huge gains. QCOR bought the drug for $100K in 2001, planning to produce it only to treat infantile spasms. But thanks to aggressive marketing, it's now being prescribed for MS, arthritis, and kidney disease. Aetna's (AET) decision to limit off-label treatments has hit shares, but it's not clear any viable alternatives are on the horizon. (NYT) 32 Comments

1
2
3
4
5
6
...
11
Next Page